HER 2 NEGATIVE BREAST CANCER
Clinical trials for HER 2 NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER 2 NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for HER 2 NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat breast cancer
Disease control Recruiting nowThis study is testing a combination of two drugs, utidelone and bevacizumab, in people with advanced HER-2 negative breast cancer who have already tried at least two other treatments. The goal is to see if this combination can slow down the cancer's growth and improve outcomes. A…
Matched conditions: HER 2 NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New hope for tough breast cancer: Two-Drug combo tested
Disease control Recruiting nowThis study tests a combination of two drugs, eribulin and anlotinib, for people with HER2-negative breast cancer that has spread or come back. Participants have already tried other treatments without success. The goal is to see if this combo can slow cancer growth and improve sur…
Matched conditions: HER 2 NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC